Document Type : Review Article
Authors
1 Department of biomedical engineering, Faculty of engineering, Maziar university, Royan, Iran
2 Build Goal Health, Inc Ceo & Founder, Los Angles, California, United States.
Abstract
It has been known for quite some time that gut microbiota plays an important role in human health and illness. Recent years have seen a surge in interest in the human gut microbiota, and the advent of metagenomic investigations has greatly aided our understanding of the resident species and their potential uses. The human digestive tract is home to billions of bacteria, making up the varied gut microbiota. At birth, the gut microbiome begins to take shape and proliferate, and throughout life, numerous genetic, dietary, and environmental variables will shape and multiply this community. Alterations to the gut microbiota's structure and function may affect digestion, metabolism, and the immune system. Meanwhile, personalized medicine, a new therapeutic approach, has opened a new door in the medical sciences, and the link between the microbiome and personalized medicine is one of the most intriguing areas of study going forward. Since the link between this two axis is new, there are few research on it. Therefore, in this review study, the relationship between the gut microbiome, drug interactions, disease progression, and personalized medicine has been discussed.
Keywords
gut microbiota for precision medicine: Focusing on the
efficacy and toxicity of drugs. Theranostics. 2020 ; 10(24),
11278–11301.
2.Budnitz, D. S., Lovegrove, M. C., & Crosby, A.
E. Emergency department visits for overdoses of
acetaminophen-containing products. American journal of
preventive medicine. 2011 ; 40(6), 585-592.
3.Behrouzi, A., Nafari, A. H., & Siadat, S. D. The significance
of microbiome in personalized medicine. Clinical and
translational medicine. 2019 ; 8, 1-9.
4.Hisada, T., Endoh, K., & Kuriki, K. Inter-and intraindividual variations in seasonal and daily stabilities
of the human gut microbiota in Japanese. Archives of
microbiology. 2015 ; 197, 919-934.
5.Qin, J., Li, R., Raes, J., Arumugam, M., Burgdorf, K. S.,
Manichanh, C., ... & Wang, J. A human gut microbial gene
catalogue established by metagenomic sequencing. nature.
2010 ; 464(7285), 59-65.
6.Scheline, R. R. Metabolism of foreign compounds by
gastrointestinal microorganisms. Pharmacological
reviews. 1973 ; 25(4), 451-523.
7.Amedei, A., & Boem, F. I’ve gut a feeling: microbiota
impacting the conceptual and experimental perspectives of
personalized medicine. International journal of molecular
sciences. 2018 ; 19(12), 3756.
8. Li, H., He, J., & Jia, W. The influence of gut microbiota
on drug metabolism and toxicity. Expert opinion on drug
metabolism & toxicology. 2016 ; 12(1), 31-40.
9. Di, L. The role of drug metabolizing enzymes in
clearance. Expert opinion on drug metabolism &
toxicology. 2014 ; 10(3), 379-393.
10.Cho, I., & Blaser, M. J. The human microbiome: at the
interface of health and disease. Nature Reviews Genetics.
2012 ; 13(4), 260-270.
11.Li, H., & Jia, W. Cometabolism of microbes and host:
implications for drug metabolism and drug‐induced
toxicity. Clinical Pharmacology & Therapeutics. 2013
; 94(5), 574-581.
12.Currò, D.The role of gut microbiota in the modulation
of drug action: a focus on some clinically significant
issues. Expert Review of Clinical Pharmacology. 2018;
11(2), 171-183.
13.Brochado, A. R., Telzerow, A., Bobonis, J., Banzhaf, M.,
Mateus, A., Selkrig, J., ... & Typas, A. Species-specific
activity of antibacterial drug combinations. Nature. 2018
; 559(7713), 259-263.
14.Nakayama, H., Kinouchi, T., Kataoka, K., Akimoto,
S., Matsuda, Y., & Ohnishi, Y. Intestinal anaerobic
Tahereh Mehdizadeh et al Pers M J
13
bacteria hydrolyse sorivudine, producing the high blood
concentration of 5-(E)-(2-bromovinyl) uracil that increases
the level and toxicity of 5-fluorouracil. Pharmacogenetics.
1997 ; 7(1), 35-43.
15.Hanahan, D.Hallmarks of cancer: A 2012
perspective. Annals of oncology, 23, ix23. 2012.
16.Contreras, A. V., Cocom-Chan, B., Hernandez-Montes,
G., Portillo-Bobadilla, T., & Resendis-Antonio, O. Hostmicrobiome interaction and cancer: potential application
in precision medicine. Frontiers in physiology. 2016 ; 7,
606.
17.Debunne, N., Wynendaele, E., Janssens, Y., De Spiegeleer,
A., Verbeke, F., Tack, L., ... & De Spiegeleer, B. The
quorum sensing peptide EntF* promotes colorectal cancer
metastasis in mice: a new factor in the microbiome-host
interaction. BioRxiv. 2020 ; 2020-09.
18.Kong, C., Liang, L., Liu, G., Du, L., Yang, Y., Liu, J., ... &
Ma, Y. Integrated metagenomic and metabolomic analysis
reveals distinct gut-microbiome-derived phenotypes in
early-onset colorectal cancer. Gut. 2023; 72(6), 1129-1142.
19.Marion, S. A. M. Biogeography and biochemistry of
bile acid 7-dehydroxylation in the mammalian gut (No.
THESIS). EPFL. 2020.
20.Quast, C., Pruesse, E., Yilmaz, P., Gerken, J., Schweer,
T., Yarza, P., ... & Glöckner, F. O. The SILVA ribosomal
RNA gene database project: improved data processing and
web-based tools. Nucleic acids research. 2012; 41(D1),
D590-D596.
21.Portincasa, P., Bonfrate, L., Vacca, M., De Angelis, M.,
Farella, I., Lanza, E., ... & Di Ciaula, A. Gut microbiota
and short chain fatty acids: implications in glucose
homeostasis. International journal of molecular sciences.
2022 ; 23(3), 1105.
22.Aderinto, N., & Olatunji, G. D. The role of microbiome
analysis in precision medicine and personalized
nutrition for improving health outcomes in Africa: a
correspondence. IJS Global Health. 2023 ; 6(3), e137.
23.Li, X., Guo, J., Ji, K., & Zhang, P. Bamboo shoot
fiber prevents obesity in mice by modulating the gut
microbiota. Scientific reports. 2016 ; 6(1), 32953.
24.Baker, J. L., Shriner, D., Bentley, A. R., & Rotimi, C. N.
Pharmacogenomic implications of the evolutionary history
of infectious diseases in Africa. The pharmacogenomics
journal. 2017 ; 17(2), 112-120.
25.Lu, Y., Yuan, X., Wang, M., He, Z., Li, H., Wang, J., &
Li, Q. Gut microbiota influence immunotherapy responses:
mechanisms and therapeutic strategies. Journal of
hematology & oncology. 2022 ; 15(1), 47.
26.Stancu A. L. Gut Microbiome and the Response to
Immunotherapy in Cancer. Discoveries (Craiova,
Romania). 2018 ; 6(3), e84.
27.Davidovics, Z. H., Michail, S., Nicholson, M. R., Kociolek,
L. K., Pai, N., Hansen, R., Schwerd, T., Maspons, A.,
Shamir, R., Szajewska, H., Thapar, N., de Meij, T., Mosca,
A., Vandenplas, Y., Kahn, S. A., Kellermayer, R., & FMT
Special Interest Group of the North American Society
of Pediatric Gastroenterology Hepatology, Nutrition,
the European Society for Pediatric Gastroenterology
Hepatology, Nutrition Fecal Microbiota Transplantation
for Recurrent Clostridium difficile Infection and Other
Conditions in Children: A Joint Position Paper From the
North American Society for Pediatric Gastroenterology,
Hepatology, and Nutrition and the European Society
for Pediatric Gastroenterology, Hepatology, and
Nutrition. Journal of pediatric gastroenterology and
nutrition. 2019 ; 68(1), 130–143.
28.Cristofori, F., Dargenio, V. N., Dargenio, C., Miniello,
V. L., Barone, M., & Francavilla, R. Anti-Inflammatory
and Immunomodulatory Effects of Probiotics in
Gut Inflammation: A Door to the Body. Frontiers in
immunology. 2021 ; 12, 578386.
29.El-Sayed, A., Aleya, L., & Kamel, M. The link
among microbiota, epigenetics, and disease
development. Environmental Science and Pollution
Research. 2021 ; 28, 28926-28964.
30.Blanton, L. V., Barratt, M. J., Charbonneau, M. R., Ahmed,
T., & Gordon, J. I. Childhood undernutrition, the gut
microbiota, and microbiota-directed therapeutics. Science.
2016 ; 352(6293), 1533-1533.
31.Rajakovich, L. J., & Balskus, E. P. Metabolic functions
of the human gut microbiota: the role of metalloenzymes.
Natural product reports. 2019 ; 36(4), 593-625.
32.Wang, Z., Roberts, A. B., Buffa, J. A., Levison, B. S., Zhu,
W., Org, E., ... & Hazen, S. L. Non-lethal inhibition of gut
microbial trimethylamine production for the treatment of
atherosclerosis. Cell. 2015 ; 163(7), 1585-1595.
33.Marchesi, J. R., Adams, D. H., Fava, F., Hermes, G.
D., Hirschfield, G. M., Hold, G., ... & Hart, A. The gut
microbiota and host health: a new clinical frontier. Gut.
2016 ; 65(2), 330-339.
34.Singh, R. K., Chang, H. W., Yan, D., Lee, K. M., Ucmak,
D., Wong, K., Abrouk, M., Farahnik, B., Nakamura, M.,
Zhu, T. H., Bhutani, T., & Liao, W. Influence of diet on the
gut microbiome and implications for human health.Journal
of translational medicine. 2017 ; 15(1), 73.
35.Zeevi, D., Korem, T., Zmora, N., Israeli, D., Rothschild,
D., Weinberger, A., ... & Segal, E. Personalized nutrition
by prediction of glycemic responses. Cell. 2015; 163(5),
1079-1094.
)